3 Biotechs Investors Should Watch
The healthcare version of Where the Money Is.
Why VIVUS, Inc. Is Today's Best Biotech Stock
VIVUS stock is among today's top gainers after announcing the supplemental new drug approval for erectile dysfunction drug Stendra. Find out how this could impact VIVUS and its shareholders moving forward.
5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know
Highlights from Arena Pharmaceuticals' conference call with investors.